Biostage (BSTG) Reports Q4 Loss of $0.20/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. GNK
2. SPY
3. AZN
4. AGPU
5. USO
6. HIVE
7. GSAT
8. S
9. RKLB
10. OABI

Go back to Biostage (BSTG) Reports Q4 Loss of $0.20/Share

Biostage Reports 2016 Financial Results and Provides Business Update

March 9, 2017 7:35 AM EST

HOLLISTON, Mass., March 9, 2017 /PRNewswire/ -- Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea, today announced financial results for the quarter and year ended December 31, 2016.

The Company also provided an update to its corporate and clinical progress and reviewed its expected near-term milestones. As previously announced, Biostage management will host... More